Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma.
Loading...
Embargo End Date
Authors
Kerrison, WGJ
Ning, J
Krasny, L
Arthur, A
Guljar, N
Elms, ML
Swain, A
Jones, RL
Thway, K
Huang, PH
Ning, J
Krasny, L
Arthur, A
Guljar, N
Elms, ML
Swain, A
Jones, RL
Thway, K
Huang, PH
Document Type
Journal Article
Date
2022-08-04
Date Accepted
2022-08-03
Abstract
Synovial sarcoma is a rare translocation-driven cancer with poor survival outcomes, particularly in the advanced setting. Previous synovial sarcoma preclinical studies have relied on a small panel of cell lines which suffer from the limitation of genomic and phenotypic drift as a result of being grown in culture for decades. Patient-derived xenografts (PDX) are a valuable tool for preclinical research as they retain many histopathological features of their originating human tumour; however, this approach is expensive, slow, and resource intensive, which hinders their utility in large-scale functional genomic and drug screens. To address some of these limitations, in this study, we have established and characterised a novel synovial sarcoma cell line, ICR-SS-1, which is derived from a PDX model and is amenable to high-throughput drug screens. We show that ICR-SS-1 grows readily in culture, retains the pathognomonic SS18::SSX1 fusion gene, and recapitulates the molecular features of human synovial sarcoma tumours as shown by proteomic profiling. Comparative analysis of drug response profiles with two other established synovial sarcoma cell lines (SYO-1 and HS-SY-II) finds that ICR-SS-1 harbours intrinsic resistance to doxorubicin and is sensitive to targeted inhibition of several oncogenic pathways including the PI3K-mTOR pathway. Collectively, our studies show that the ICR-SS-1 cell line model may be a valuable preclinical tool for studying the biology of anthracycline-resistant synovial sarcoma and identifying new salvage therapies following failure of doxorubicin.
Citation
Cells, 2022, 11 (15), pp. 2418 - 2418
Source Title
Cells
Publisher
MDPI
ISSN
eISSN
2073-4409
2073-4409
2073-4409
Collections
Research Team
Mol and Systems Oncology